Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
Open Access
- 1 October 1991
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 88 (4) , 1155-1160
- https://doi.org/10.1172/jci115416
Abstract
In this study the contribution of activation of the contact system to activation of the fibrinolytic system in vivo was investigated in healthy volunteers and in factor XII deficient patients. The plasminogen activating activity in plasma from healthy volunteers after infusion of desamino D-arginine vasopressin (DDAVP) was only partially blocked (for 77%) with specific antibodies to tissue-type plasminogen activator and urokinase type plasminogen activator. The residual activity could be quenched by a monoclonal antibody that inhibits factor XII activity and was not present in patients with a factor XII deficiency. The formation of plasmin upon the DDAVP stimulus as reflected by circulating plasmin-alpha 2-antiplasmin complexes was lower in factor XII deficient patients than in healthy volunteers. Activation of the contact system occurred after DDAVP infusion in healthy volunteers and was absent in factor XII deficient patients. These results indicate that DDAVP induces a plasminogen activating activity that is partially dependent on activation of the contact system and that contributes to the overall fibrinolytic activity as indicated by the formation of plasmin-alpha 2-antiplasmin complexes. This fibrinolytic activity is impaired in factor XII deficient patients which may explain the occurrence of thromboembolic complications in these patients.Keywords
This publication has 28 references indexed in Scilit:
- Thromboembolism and Bleeding Tendency in Congenital Factor XII DeficienCy - A Study on 74 Subjects from 14 Swiss FamiliesThrombosis and Haemostasis, 1991
- The Contact-System Dependent Plasminogen Activator from Human Plasma: Identification and CharacterizationThrombosis and Haemostasis, 1990
- DDAVP Induces Systemic Release of Urokinase-Type Plasminogen ActivatorThrombosis and Haemostasis, 1989
- QUANTIFICATION OF PLASMA FACTOR XIIA-CL-INHIBITOR AND KALLIKREIN-CL-INHIBITOR COMPLEXES IN SEPSIS1988
- Role of the Contact System in FibrinolysisSeminars in Thrombosis and Hemostasis, 1987
- Quantitation of urokinase antigen in plasma and culture media by use of an elisaThrombosis Research, 1986
- Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PAThrombosis and Haemostasis, 1985
- TISSUE PLASMINOGEN-ACTIVATOR RELEASE INVIVO IN RESPONSE TO VASOACTIVE AGENTS1985
- The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.Journal of Clinical Investigation, 1978
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1971